Works about FIBROSIS

Results: 5000
    1
    2

    Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General Population.

    Published in:
    Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70169
    By:
    • van Son, Koen C.;
    • de Jong, Jelle C. B. C.;
    • Özsezen, Serdar;
    • Caspers, Martien P. M.;
    • Augustijn, Quinten J. J.;
    • Snabel, Jessica;
    • Galenkamp, Henrike;
    • Hamer, Henrike M.;
    • van Dijk, Anne‐Marieke;
    • van Koppen, Arianne;
    • Mak, Anne Linde;
    • van den Born, Bert‐Jan;
    • Nieuwdorp, Max;
    • Drenth, Joost P. H.;
    • Gluud, Lise Lotte;
    • Tushuizen, Maarten E.;
    • Hanemaaijer, Roeland;
    • Verschuren, Lars;
    • Holleboom, Adriaan G.
    Publication type:
    Article
    3
    4
    5

    Genetic determinants of steatosis and fibrosis progression in paediatric non‐alcoholic fatty liver disease.

    Published in:
    Liver International, 2019, v. 39, n. 3, p. 540, doi. 10.1111/liv.14006
    By:
    • Hudert, Christian A.;
    • Wiegand, Susanna;
    • Selinski, Silvia;
    • Golka, Klaus;
    • Cadenas, Cristina;
    • Reinders, Jörg;
    • Hengstler, Jan G.;
    • Rudolph, Birgit;
    • Bläker, Hendrik;
    • Loddenkemper, Christoph;
    • Thielhorn, Ria;
    • Meierhofer, David;
    • Berndt, Nikolaus;
    • Holzhütter, Hermann‐Georg;
    • Henning, Stephan;
    • Bufler, Philip;
    • Jansen, Peter L. M.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment.

    Published in:
    Liver International, 2018, v. 38, n. 6, p. 1028, doi. 10.1111/liv.13629
    By:
    • Kozbial, Karin;
    • Moser, Stephan;
    • Al‐Zoairy, Ramona;
    • Schwarzer, Remy;
    • Datz, Christian;
    • Stauber, Rudolf;
    • Laferl, Hermann;
    • Strasser, Michael;
    • Beinhardt, Sandra;
    • Stättermayer, Albert F.;
    • Gschwantler, Michael;
    • Zoller, Heinz;
    • Maieron, Andreas;
    • Graziadei, Ivo;
    • Trauner, Michael;
    • Steindl‐Munda, Petra;
    • Hofer, Harald;
    • Ferenci, Peter
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects.

    Published in:
    Liver International, 2018, v. 38, n. 1, p. 155, doi. 10.1111/liv.13505
    By:
    • Giraudi, Pablo J.;
    • Gambaro, Sabrina E.;
    • Ornelas Arroyo, Sofia;
    • Chackelevicius, Carla M.;
    • Giuricin, Michela;
    • Silvestri, Marta;
    • Macor, Daniele;
    • Crocé, Lory S.;
    • Bonazza, Deborah;
    • Soardo, Giorgio;
    • de Manzini, Nicolò;
    • Zanconati, Fabrizio;
    • Tiribelli, Claudio;
    • Palmisano, Silvia;
    • Rosso, Natalia
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35

    Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.

    Published in:
    Liver International, 2017, v. 37, n. 10, p. 1544, doi. 10.1111/liv.13451
    By:
    • Traussnigg, Stefan;
    • Kienbacher, Christian;
    • Gajdošík, Martin;
    • Valkovič, Ladislav;
    • Halilbasic, Emina;
    • Stift, Judith;
    • Rechling, Christian;
    • Hofer, Harald;
    • Steindl ‐ Munda, Petra;
    • Ferenci, Peter;
    • Wrba, Fritz;
    • Trattnig, Siegfried;
    • Krššák, Martin;
    • Trauner, Michael
    Publication type:
    Article
    36

    Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.

    Published in:
    Liver International, 2017, v. 37, n. 10, p. 1554, doi. 10.1111/liv.13402
    By:
    • Vries, Elisabeth M.G.;
    • Färkkilä, Martti;
    • Milkiewicz, Piotr;
    • Hov, Johannes R.;
    • Eksteen, Bertus;
    • Thorburn, Douglas;
    • Chazouillères, Olivier;
    • Pares, Albert;
    • Nygård, Ståle;
    • Gilja, Odd H.;
    • Wunsch, Ewa;
    • Invernizzi, Pietro;
    • Carbone, Marco;
    • Bernuzzi, Francesca;
    • Boberg, Kirsten M.;
    • Røsjø, Helge;
    • Rosenberg, William;
    • Beuers, Ulrich H.;
    • Ponsioen, Cyriel Y.;
    • Karlsen, Tom H.
    Publication type:
    Article
    37
    38

    Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.

    Published in:
    Liver International, 2017, v. 37, n. 9, p. 1314, doi. 10.1111/liv.13383
    By:
    • Hézode, Christophe;
    • Lebray, Pascal;
    • De Ledinghen, Victor;
    • Zoulim, Fabien;
    • Di Martino, Vincent;
    • Boyer, Nathalie;
    • Larrey, Dominique;
    • Botta ‐ Fridlund, Danielle;
    • Silvain, Christine;
    • Fontaine, Hélène;
    • D'Alteroche, Louis;
    • Leroy, Vincent;
    • Bourliere, Marc;
    • Hubert ‐ Fouchard, Isabelle;
    • Guyader, Dominique;
    • Rosa, Isabelle;
    • Nguyen ‐ Khac, Eric;
    • Fedchuk, Larysa;
    • Akremi, Raoudha;
    • Bennai, Yacia
    Publication type:
    Article
    39
    40
    41
    42

    Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.

    Published in:
    Liver International, 2017, v. 37, n. 3, p. 369, doi. 10.1111/liv.13256
    By:
    • Bachofner, Jacqueline A.;
    • Valli, Piero V.;
    • Kröger, Arne;
    • Bergamin, Irina;
    • Künzler, Patrizia;
    • Baserga, Adriana;
    • Braun, Dominique;
    • Seifert, Burkhardt;
    • Moncsek, Anja;
    • Fehr, Jan;
    • Semela, David;
    • Magenta, Lorenzo;
    • Müllhaupt, Beat;
    • Terziroli Beretta ‐ Piccoli, Benedetta;
    • Mertens, Joachim C.
    Publication type:
    Article
    43
    44
    45
    46
    47

    Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.

    Published in:
    Liver International, 2016, v. 36, n. 12, p. 1783, doi. 10.1111/liv.13177
    By:
    • Meissner, Eric G.;
    • McLaughlin, Mary;
    • Matthews, Lindsay;
    • Gharib, Ahmed M.;
    • Wood, Bradford J.;
    • Levy, Elliot;
    • Sinkus, Ralph;
    • Virtaneva, Kimmo;
    • Sturdevant, Dan;
    • Martens, Craig;
    • Porcella, Stephen F.;
    • Goodman, Zachary D.;
    • Kanwar, Bittoo;
    • Myers, Robert P.;
    • Subramanian, Mani;
    • Hadigan, Colleen;
    • Masur, Henry;
    • Kleiner, David E.;
    • Heller, Theo;
    • Kottilil, Shyam
    Publication type:
    Article
    48
    49

    IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.

    Published in:
    Liver International, 2016, v. 36, n. 9, p. 1258, doi. 10.1111/liv.13079
    By:
    • Jiménez-Sousa, María A.;
    • Berenguer, Juan;
    • Rallón, Norma;
    • Pineda-Tenor, Daniel;
    • Aldamiz-Echevarria, Teresa;
    • Soriano, Vicente;
    • García-Álvarez, Mónica;
    • Vazquez-Morón, Sonia;
    • Restrepo, Clara;
    • Carrero, Ana;
    • Benito, José M.;
    • Resino, Salvador
    Publication type:
    Article
    50